Many older adults show interest in getting vaccinated against respiratory syncytial virus

The first Americans over age 60 just started rolling up their sleeves to get vaccinated against respiratory syncytial virus, or RSV, now that brand-new vaccines have started to arrive at pharmacies and clinics.

Cardiovascular risks post-COVID-19 vaccination: Key findings

Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.

October 3, 2024

Biotech’s third quarter was relatively bright — with a few caveats

The weather is getting cooler, but biotech’s recovery is heating up. After a years-long wait-and-see game exhausted many industry insiders, recent signals indicate a mostly

October 5, 2024

Using a molecular testing technology for faster and comprehensive diagnosis of brain tumors

Cancer Institute Cancer Moonshot Scholars program to advance precision diagnosis of brain tumors in children.

November 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.